Longview Partners (Guernsey) LTD
Position in TMO — Thermo Fisher Scientific Inc.
CIK 1426092
ST PETER PORT, Y7
Position in TMO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$325,799,846
-$166,892,582 QoQ
Shares Held
662,828
-22.0% QoQ
Ownership
0.178%
of shares outstanding
% of Portfolio
4.83%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 64.23974243695197.ToString("F0")%
Shared 0.ToString("F0")%
None 35.76025756304803.ToString("F0")%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Longview Partners (Guernsey) LTD holds $649,395,061 across 2 Diagnostics & Research names. TMO ranks #1 (50.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
This page
|
662,828 | $325,799,846 | |
| 2 | IQV |
Iqvia Holdings Inc.
|
1,897,474 | $323,595,215 |
All Filings in TMO
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $325,799,846 | 662,828 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $492,692,428 | 850,276 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $438,247,581 | 903,566 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $352,176,474 | 868,585 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $454,898,456 | 914,185 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $505,041,364 | 970,804 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $626,034,284 | 1,012,067 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $555,062,137 | 1,003,729 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $662,067,353 | 1,139,119 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $621,931,420 | 1,171,709 | Shares | Defined | 2024-02-13 | |
| No filing history on record for this holder in this stock. | ||||||